Target intelligence / Profile preview

Ribosomal protein SA pseudogene 29 (RPSAP29)

Target
RPSAP29
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein SA pseudogene 29 (RPSAP29) is a processed pseudogene related to the RPSA gene, which encodes ribosomal protein SA, also known as the 37/67 kDa laminin receptor. RPSAP29 does not code for a functional protein and has no known biological or pathological functions. Pseudogenes like RPSAP29 commonly arise from retrotranspositional events and are not considered therapeutic targets. All functions and disease associations pertain to the functional RPSA gene, not to this pseudogene.

Other names
RPSA_6_392RPSAP29

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 29 (RPSAP29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 29 (RPSAP29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call